Comparison of the efficacy of two months of treatment with Co-trimoxasol + Rifampine versus Doxycycline + Rifampine in brucellosis

Authors

MohammadReza HassanjaniRodhan,*
*Corresponding Author: Email: [email protected]

Koomesh:Vol. 2, issue 2; 83-87
Published online:Feb 15, 2001
Article type:Research Article
How to Cite:HassanjaniRodhan M. Comparison of the efficacy of two months of treatment with Co-trimoxasol + Rifampine versus Doxycycline + Rifampine in brucellosis. koomesh. 2001;2(2):e151922. doi:

Abstract

Introduction. Treatment of brucellosis is a medical pro blem, a nd regimens of treatment with dura tion of six wee ks have significant relapse. This disease is prevalent in our country. The aim of this study was to compaire the efficacy of two months of treatment with two different regImens. Materials and Methods. From April 1998 to September 2000, this interventional study was pe rfo rmed o n patient with brucell osis in Yahyanej ad hospital in Babol. O ne of t his 2 regimens [Co-Trirnoxasol + Rifarnpin e (Re gime n I) and Doxycycline + Rifampine (Regimen II )] wa s rand omly presc rib ed and a ll cas es were foll owed for 12 months . Aft er treatment, clinical manifestations and relapses with 2 regimens were examined by Chi-Sq uaire test. Results. 66 ca se s with mean age 31.6 ± 13.7 ye ars and 63 cases with mean a ge 36 ± 15.4 years were treated by regimen I and II a nd relapse rate was 10% and 25.3% resp ectively. In compa rison to regimen II, regimen I reduced relapse rate 2.3 folds (P= 0.021). From 23 cases of re lapse, 13 ca se s were female and 10 cases were male a nd 61% of re la pse cases were occure d within six months after treatment. Conclusion. T hi s s t udy showed th at Co- t r imoxa so l + Rifampine in compa re d with Doxycycline + Rifampine is a pre fe red regime n. Follow up for o ne yea r is ne cessary following treatment according to find out re lap sing cases.

Copyright

© 2001, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Mar
2000

Comparison of three different regimens in treament of Brucellosis

MR Hassanjani Roshan,
K Hajian

Hassanjani Roshan M, Hajian K. Comparison of three different regimens in treament of Brucellosis. J Inflamm Dis. 2024;3(4):e154677. doi:

19
Dec
2006

Epidemiological, Clinical, Para clinical Aspects of Brucellosis in Imam Khomeini and Sina Hospital of Tehran (1998-2005)

A Haddadi,
M Rasoulinejad,
SH Afhami,
M Mohraz

Haddadi A, Rasoulinejad M, Afhami S, Mohraz M. Epidemiological, Clinical, Para clinical Aspects of Brucellosis in Imam Khomeini and Sina Hospital of Tehran (1998-2005). J Kermanshah Univ Med Sci. 2006;10(3):e81811. doi:

19
Jun
2010

Epidemiological, clinical, and laboratory features of brucellar meningitis: A study of 39 cases

Hosein Hatami,
Mariam Hatami,
Hamid Souri,
Alireza Janbakhsh,
Feizollah Mansouri

Hatami H, Hatami M, Souri H, Janbakhsh A, Mansouri F. Epidemiological, clinical, and laboratory features of brucellar meningitis: A study of 39 cases. J Kermanshah Univ Med Sci. 2010;14(1):e79544. doi:

8
Jun
2021
Epidemiology, Clinical and Laboratory Manifestations, and Outcomes of Brucellosis Among 104 Patients in Referral Hospitals of Tehran, Iran

Epidemiology, Clinical and Laboratory Manifestations, and Outcomes of Brucellosis Among 104 Patients in Referral Hospitals of Tehran, Iran

Amirreza Keyvanfar,
Shahnaz Sali,
Amir Zamani

Keyvanfar A, Sali S, Zamani A. Epidemiology, Clinical and Laboratory Manifestations, and Outcomes of Brucellosis Among 104 Patients in Referral Hospitals of Tehran, Iran. Arch Clin Infect Dis. 2021;16(2):e111546. doi: https://doi.org/10.5812/archcid.111546

9
Apr
2016

Different Clinical Presentations of Brucellosis

Mohammad Reza Hasanjani Roushan,
Soheil Ebrahimpour,
Zahra Moulana

Hasanjani Roushan MR, Ebrahimpour S, Moulana Z. Different Clinical Presentations of Brucellosis. Jundishapur J Microbiol. 2016;9(4):e33765. doi: https://doi.org/10.5812/jjm.33765

More by these authors

MohammadReza HassanjaniRodhanPubMedScholar
Share
Cited by
Metrics